Treatment

Since the beginning we made exchange of medical and psychological information with our patients to determine eligibility for treatment with IBOGAINE. And we evaluate their intention to change according to Prochaska and Di Clemente change model. Depending on their condition, patients are stabilized by possible acute withdrawal, restitution of liquids and electrolytes; we checked the intestinal toilette and other previous procedures. EKG are performed as needed, before, during and after the treatment, and a complete medical evaluation is done, plus liver profile, drugs panel and some other examination according to the criteria of the medical director. High purity IBOGAINE is orally administered in soft gelatin capsules and the appropriate dose for each patient is calculated according to variables such as age, substances of consumption and body weight, according to established protocols and agreed with other doctors and facilitators of IBOGAINE worldwide. In our model the entire therapeutic administration of Ibogaine procedure is performed in a General Hospitals Jordan and Yarden Hospitals in Guatemala City, being one of the few places in the world where it is done this way to ensure medical safety and comfort of our patients. All the procedure is supervised by the medical director, medical and paramedical staff of the hospitals and an exclusive nurse for the patient, who has many years of experience in supervision of patients who have been, administered IBOGAINE. Most of our staff, beginning with our medical director, Dr. Lopez Martinez, our coach, administrative personal, staff and nurses, has received IBOGAINE for research purposes and training so their knowledge about the procedure, the effects and experience are firsthand. Electronic monitoring and staff is carried out in a quiet and friendly enviroment. The hospitalization period varies from 48 to 96 hours. Subsequently, the patient enters in the follow up phase that in most involves the use of boosters doses of IBOGAINE, and many times, not addictive medications for the proper treatment of Post-Acute Withdrawal P.A.W. while training in social skills such as proper Stress management, Social Skills Development and proper management of Painful affect having identified the latter as one of the most common triggers of relapse.

We aim to the correct treatment of dual-diagnoses for other neurological disorders that can abort the normal process after IBOGAINE administration. Our patients are followed then, through personal meetings, telephone communication, via email or weekly videoconferences. All patients are suggested to attend any organized group mainly A.A. or N.A. as cognitive behavioral strategy. We try also to give family guidance on the proper way to accompany the patient in emerging phase of the recuperative process.